Enovis (ENOV) Liabilities from Discontinued Operations (2016 - 2025)
Enovis' (ENOV) quarterly Liabilities from Discontinued Operations came in at 1425000.0 in Q4 2025, down 99.75% on a QoQ basis from 573562000.0 in Q4 2021.
Enovis (ENOV) Liabilities from Discontinued Operations (2016 - 2025) Analysis & Trends
Enovis (ENOV) has 6 years of Liabilities from Discontinued Operations data on file, last reported at 1425000.0 in Q4 2025.
- On a quarterly basis, Liabilities from Discontinued Operations changed N/A year-over-year to 1425000.0 in Q4 2025; TTM through Oct 2025 was 1425000.0, a N/A change from a year earlier, with the FY2021 full-year figure at 573562000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations for Q4 2025 stood at 1425000.0, down from 573562000.0 in the prior quarter.
- Over the last five years, Liabilities from Discontinued Operations for ENOV reached as high as 573562000.0 in Q4 2021 and fell as low as 1425000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.55 Bn | 176.26 Bn | 6.27 Bn |
| 2 | Stryker | 128.64 Bn | 125.76 Bn | 3.81 Bn |
| 3 | Medtronic | 108.92 Bn | 99.70 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.84 Bn | 44.17 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.25 Bn | 25.96 Bn | 1.98 Bn |
| 7 | Dexcom | 28.23 Bn | 27.11 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.30 Bn | 2.07 Bn |
| 10 | Enovis | 1.60 Bn | 1.57 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 3, 2025 | 1.43 Mn |
| Oct 3, 2025 | 1.43 Mn |
| Dec 31, 2021 | 573.56 Mn |
| Dec 31, 2021 | 573.56 Mn |
| Sep 27, 2019 | 651.72 Mn |
| Sep 27, 2019 | 651.72 Mn |
| Dec 31, 2018 | 95.40 Mn |
| Dec 31, 2018 | 95.40 Mn |
| Sep 29, 2017 | 272.41 Mn |
| Sep 29, 2017 | 272.41 Mn |
| Dec 31, 2016 | 165.97 Mn |
| Dec 31, 2016 | 165.97 Mn |